Skip to content
Small Cell Lung Cancer: Established & Recent Advances episode artwork

Aug 23, 2018 23 min

Small Cell Lung Cancer: Established & Recent Advances

from OncoPharm Hosted by John Bossaer

Small cell lung cancer is reviewed, including the milestone advances (chemo + RT, omitting surgery, cis/etoposide) of the past leading up to the latest advance (15:20) - FDA-approval of nivolumab in the 3rd-line setting.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Small Cell Lung Cancer: Established & Recent Advances

0:00 23:46

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of OncoPharm?

This episode is 23 minutes long.

When was this OncoPharm episode published?

This episode was published on August 23, 2018.

Can I download this OncoPharm episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.